Alexion Pharmaceuticals, Inc.
NASDAQ: ALXN
$182.50
+$0.00 (+0.0%)
Closing Price on July 28, 2021
ALXN Articles
The December 15 short interest data have been compared with the previous report, and short interest was down in most of the selected biotech stocks.
Published:
Last Updated:
In a new research report, the biotech team at RBC reveal their top picks for 2017, and while hardly pounding the table, they are cautiously optimistic.
Published:
Last Updated:
Thursday’s top analyst upgrades, downgrades and initiations include Advanced Micro Devices, Comerica, General Mills, Mastercard and Vertex Pharmaceuticals.
Published:
Last Updated:
December 13, 2016: Here are four stocks trading with relatively heavy volume among 41 equities making new 52-week lows in Tuesday’s session. On the NYSE, advancers led decliners by about 3 to 2 and...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Amgen, Coca-Cola, IBM, Procter & Gamble, Viacom, SeaWorld and NovoCure.
Published:
Last Updated:
December 12, 2016: Here are four stocks trading with relatively heavy volume among 28 equities making new 52-week lows in Monday’s session. On the NYSE, decliners led advancers by nearly 2 to 1 and...
Published:
Last Updated:
Alexion Pharmaceuticals saw its shares slide on Monday after the company reported a change in its executive team.
Published:
Last Updated:
The November 30 short interest data have been compared with the previous report, and short interest was mixed in the selected biotech stocks.
Published:
Last Updated:
The November 15 short interest data have been compared with the previous report, and short interest increased in most of the selected biotech stocks.
Published:
Last Updated:
With the Republicans now set to control both Congress and the White House, many on Wall Street feel that there could be far less scrutiny on drug pricing.
Published:
Last Updated:
Now that the U.S. presidential election is over and Hillary Clinton is out of the picture, major biotech companies can breathe a little easier knowing that the pressure is off, if for just now at...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Brocade Communications Systems, Facebook, First Solar, Fitbit, ONEOK Partners and Sunrun.
Published:
Last Updated:
The October 14 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
Last Updated:
If a single failed clinical trial can mean disaster for a biotech stock, then short sellers can argue for a stock implosion down the road.
Published:
Last Updated:
The September 15 short interest data have been compared with the previous report, and short interest moves were upward across most of these selected biotech stocks.
Published:
Last Updated: